EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; pol |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TAKAHASHI, TOMOHIRO MIYAZAWA, TADASHI MATSUDA, MUNETOMO OMURA, TOMOYUKI HAYAMA, TETSUO HAYASHI, KOUJI |
description | This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL3875085TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL3875085TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL3875085TT33</originalsourceid><addsrcrecordid>eNrjZNBxdXEMcgzz93NVCA4NDnD1C_b091Nw8w9S8A9y9FFwdPH19PMMDglyDAGK8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-AAfYwtzUwML05AQY2Ni1AAAxeUmDA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><source>esp@cenet</source><creator>TAKAHASHI, TOMOHIRO ; MIYAZAWA, TADASHI ; MATSUDA, MUNETOMO ; OMURA, TOMOYUKI ; HAYAMA, TETSUO ; HAYASHI, KOUJI</creator><creatorcontrib>TAKAHASHI, TOMOHIRO ; MIYAZAWA, TADASHI ; MATSUDA, MUNETOMO ; OMURA, TOMOYUKI ; HAYAMA, TETSUO ; HAYASHI, KOUJI</creatorcontrib><description>This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.</description><language>eng ; pol</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241021&DB=EPODOC&CC=PL&NR=3875085T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241021&DB=EPODOC&CC=PL&NR=3875085T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAKAHASHI, TOMOHIRO</creatorcontrib><creatorcontrib>MIYAZAWA, TADASHI</creatorcontrib><creatorcontrib>MATSUDA, MUNETOMO</creatorcontrib><creatorcontrib>OMURA, TOMOYUKI</creatorcontrib><creatorcontrib>HAYAMA, TETSUO</creatorcontrib><creatorcontrib>HAYASHI, KOUJI</creatorcontrib><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><description>This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBxdXEMcgzz93NVCA4NDnD1C_b091Nw8w9S8A9y9FFwdPH19PMMDglyDAGK8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSS-AAfYwtzUwML05AQY2Ni1AAAxeUmDA</recordid><startdate>20241021</startdate><enddate>20241021</enddate><creator>TAKAHASHI, TOMOHIRO</creator><creator>MIYAZAWA, TADASHI</creator><creator>MATSUDA, MUNETOMO</creator><creator>OMURA, TOMOYUKI</creator><creator>HAYAMA, TETSUO</creator><creator>HAYASHI, KOUJI</creator><scope>EVB</scope></search><sort><creationdate>20241021</creationdate><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><author>TAKAHASHI, TOMOHIRO ; MIYAZAWA, TADASHI ; MATSUDA, MUNETOMO ; OMURA, TOMOYUKI ; HAYAMA, TETSUO ; HAYASHI, KOUJI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL3875085TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKAHASHI, TOMOHIRO</creatorcontrib><creatorcontrib>MIYAZAWA, TADASHI</creatorcontrib><creatorcontrib>MATSUDA, MUNETOMO</creatorcontrib><creatorcontrib>OMURA, TOMOYUKI</creatorcontrib><creatorcontrib>HAYAMA, TETSUO</creatorcontrib><creatorcontrib>HAYASHI, KOUJI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAKAHASHI, TOMOHIRO</au><au>MIYAZAWA, TADASHI</au><au>MATSUDA, MUNETOMO</au><au>OMURA, TOMOYUKI</au><au>HAYAMA, TETSUO</au><au>HAYASHI, KOUJI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION</title><date>2024-10-21</date><risdate>2024</risdate><abstract>This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; pol |
recordid | cdi_epo_espacenet_PL3875085TT3 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A22%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAKAHASHI,%20TOMOHIRO&rft.date=2024-10-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL3875085TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |